Professor LIU Wanli's experience in treating refractory gastroesophageal reflux disease through the theory of relieving depression and lowering stomach Qi
-
摘要: 难治性胃食管反流病是临床疑难病，单纯西药抑酸治疗难收佳效，抗反流治疗的失效是该病难治、难愈的重要原因。该病以胃失和降为基本病机，存在气血怫郁、脏腑失调的病理状态，可以表现为因郁致病和因病致郁。刘万里教授诊疗该病从解郁通降立法，以化解郁滞、助胃通降为诊治思路的核心，重点治疗烧心、反酸、咽部不适、胸痛等难治症状，自拟经验处方降逆汤、通降合剂，能够增强抗反流的治疗效果，达到通胃滞、行气血、降浊逆的目的。Abstract: Refractory gastroesophageal reflux disease is a clinically challenging condition, and acid-suppressing drug therapy often fails to achieve satisfactory results. The disease is characterized by the inability of stomach Qi to descend, presenting a pathological state of stagnation and obstruction. Professor LIU Wanli focuses on the treatment of difficult symptoms such as heartburn, acid reflux, pharyngeal obstruction and chest pain, summarizes effective empirical prescriptions, and enhances the anti-reflux treatment effect. The treatment of this disease can employ methods to resolve stagnation and promote the descent of stomach Qi, including regulating Qi movement, removing phlegm-dampness, and clearing heat. Methods such as promoting blood circulation to remove stasis and eliminating food accumulation, along with regulating emotions, can enhance the therapeutic effect.
-
-
[1] Katz PO, Dunbar KB, Schnoll-sussman FH, et al. Acg clinical guideline for the diagnosis and management of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2022, 117(1): 27-56. doi: 10.14309/ajg.0000000000001538
[2] Chapelle N, Ghezala IB, Barkun A, et al. The pharmacotherapeutic management of gastroesophageal reflux disease(GERD)[J]. Expert Opin Pharmacother, 2021, 22(2): 219-227. doi: 10.1080/14656566.2020.1817385
[3] Ugliono E, Rebecchi F, Mantova S, et al. Laparoscopic antireflux surgery for refractory gastroesophageal reflux disease: long-term clinical outcomes[J]. Updates Surg, 2023, 75(4): 979-986. doi: 10.1007/s13304-023-01483-x
[4] 中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663. doi: 10.3760/cma.j.cn311367-20200918-00558
[5] 邹多武. 难治性胃食管反流病的诊疗策略[J]. 中国实用内科杂志, 2020, 40(2): 89-91.
[6] 袁莉莉, 季锋, 李治仝, 等. 合并食管外症状的难治性胃食管反流病的临床研究[J]. 中华消化杂志, 2020, 40(1): 45-47.
[7] Naik RD, Meyers MH, Vaezi MF. Treatment of refractory gastroesophageal reflux disease[J]. Gastroenterol Hepatol(NY), 2020, 16(4): 196-205.
[8] 张国松, 易法银. 中医之"郁"探讨[J]. 中医杂志, 2020, 61(3): 261-263.
[9] 石宇奇, 田盈, 朱明丹, 等. 《黄帝内经》"五郁"特点及治则探析[J]. 时珍国医国药, 2024, 35(1): 145-147.
[10] 中华中医药学会脾胃病分会. 胃食管反流病中医诊疗专家共识(2023)[J]. 中医杂志, 2023, 64(18): 1935-1944.
[11] Gong WM, Guo P, Li YM, et al. Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders: A Genome-Wide Pleiotropic Analysis[J]. JAMA Psychiatry, 2023, 80(4): 360-370.
[12] Tait C, Sayuk GS. The brain-gut-microbiotal axis: a framework for understanding functional GI illness and their therapeutic interventions[J]. Eur J Intern Med, 2021, 84: 1-9.
[13] 周金池, 窦维佳, 魏延, 等. 中国胃食管反流病患者焦虑抑郁患病率的Meta分析[J]. 中国全科医学, 2021, 24(5): 608-613.
[14] Mehta P, Nahass RG, Brunetti L. Acid suppression medications during hospitalization as a risk factor for recurrence of clostridioides difficile infection: systematic review and meta-analysis[J]. Clin Infect Dis, 2021, 73(1): e62-e68.
[15] Chela HK, Gangu K, Ertugrul H, et al. The 8th Wonder of the Cancer World: Esophageal cancer and inflammation[J]. Diseases, 2022, 10(3): 44.
-
计量
- 文章访问数: 151
- 施引文献: 0
下载: